Concepedia

Primo Lara

PL

11

Publications

1.1K

Citations

11

H-Index

2001

Active since

Affiliations

University of California, Davis(Current)

Oregon Health & Science University

City Of Hope National Medical Center

University of California, San Francisco

U-M Rogel Cancer Center

Primo Lara is an author at University of California, Davis specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2001–2023

11

Publications

11

Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

Rahul Aggarwal, Jiaoti Huang, Joshi J. Alumkal et al. · Journal of Clinical Oncology · 2018 · 776 citations · Full text

, , +11

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

William S. Chen, Rahul Aggarwal, Li Zhang et al. · European Urology · 2019 · 139 citations · Full text

, , +10

EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).

Christopher W. Ryan, Catherine M. Tangen, Elisabeth I. Heath et al. · Journal of Clinical Oncology · 2022 · 39 citations

, , +16

Phase II study of eribulin (E7389) in patients (pts) with advanced urothelial cancer (UC)—Final report: A California Cancer Consortium-led NCI/CTEP-sponsored trial.

David I. Quinn, Ana M. Aparicio, Denice Tsao‐Wei et al. · Journal of Clinical Oncology · 2010 · 32 citations

, , +23

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial

Primo Lara, David R. Gandara, Jeff Longmate et al. · Cancer Chemotherapy and Pharmacology · 2001 · 22 citations

, , +6

Rows per page

1–5 of 11